M&A Deal Summary

Fosun Pharma Acquires Breas Medical AB

On March 17, 2017, Fosun Pharma acquired medical products company Breas Medical AB from PBM Capital Group

Acquisition Highlights
  • This is Fosun Pharma’s 1st transaction in the Medical Products sector.
  • This is Fosun Pharma’s 1st transaction in Sweden.

M&A Deal Summary

Date 2017-03-17
Target Breas Medical AB
Sector Medical Products
Buyer(s) Fosun Pharma
Sellers(s) PBM Capital Group
Deal Type Add-on Acquisition

Target

Breas Medical AB

Mölnlycke, Sweden
Breas Medical AB is a manufacturer of home respiratory ventilators and sleep apnea products for the global home healthcare market sold in more than 40 countries.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Fosun Pharma

Shanghai, China

Category Company
Founded 1994
Sector Healthcare Services
Employees40,234
Revenue 41.1B CNY (2024)
DESCRIPTION

Fosun Pharma is a healthcare company in China that strategically covers important segments of the healthcare industry value chain, including pharmaceutical manufacturing, pharmaceutical distribution and retail, healthcare services, diagnostic products, and medical devices. Fosun Pharma was founded in 1994 and is based in Shanghai, China.


DEAL STATS #
Overall 3 of 4
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 3
Country: Sweden M&A 1 of 1
Year: 2017 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-07-28 Gland Pharma

Hyderabad, India

Gland develops and manufactures generic injectables for use in nearly 90 countries on five continents, with a focus on the Indian and US markets. Since 1996, The Company has maintained a relationship with the Vetter family in Germany, and by 2003, Gland was the first company in India to get US Food and Drug Administration ("FDA") approval for pharmaceutical liquid injectable products. Gland's world-class manufacturing facilities have also received approvals from a number of key medical regulatory agencies around the globe including those in Australia, Germany and the UK, in addition to the World Health Organization.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-12-14 Tridem Pharma

Escalquens, France

Tridem Pharma is specialized in the distribution of drugs, medical promotion and regulatory affairs in the French-speaking African countries and territories. Tridem Pharma was founded in 1986 and is based in Escalquens, France.

Buy -

Seller(S) 1

DESCRIPTION

PBM Capital Group is a private investment firm primarily focused on the healthcare and life science sectors. Prospective transaction types include management buyouts, growth financings, recapitalization, and stake purchases. PBM Capital Group was formed in 2010 and is based in Charlottesville, Virginia.


DEAL STATS #
Overall 4 of 4
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 3 of 3
Country: Sweden M&A 1 of 1
Year: 2017 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-30 Triangle Research Labs

North Carolina, United States

Triangle Research Labs LLC is a hepatocyte provider with products supporting in vitro evaluation of metabolism, drug-drug interactions, drug transporter activity, toxicity of drug candidates and other applications.

Sell -